Swaantje Casjens1, Urike Dydak2, Shalmali Dharmadhikari2, Anne Lotz3, Martin Lehnert3, Clara Quetscher3, Christoph Stewig3, Benjamin Glaubitz4, Tobias Schmidt-Wilcke5, David Edmondson2, Chien-Lin Yeh2, Tobias Weiss3, Christoph van Thriel6, Lennard Herrmann7, Siegfried Muhlack7, Dirk Woitalla7, Michael Aschner8, Thomas Brüning3, Beate Pesch3. 1. Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany. Electronic address: casjens@ipa-dguv.de. 2. School of Health Sciences, Purdue University, West Lafayette, IN, USA; Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA. 3. Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany. 4. Department of Neurology, BG University Hospital Bergmannsheil, Ruhr-Universität Bochum, Bochum, Germany. 5. Department of Neurology, BG University Hospital Bergmannsheil, Ruhr-Universität Bochum, Bochum, Germany; Institute of Clinical Neuroscience and Medical Psychology, University of Düsseldorf, Düsseldorf, Germany. 6. Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany. 7. Department of Neurology, Sankt Josef Hospital, Bochum, Germany. 8. Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York, NY, USA.
Abstract
OBJECTIVE: Magnetic resonance spectroscopy (MRS) is a non-invasive method to quantify neurometabolite concentrations in the brain. Within the framework of the WELDOX II study, we investigated the association of exposure to manganese (Mn) and iron (Fe) with γ-aminobutyric acid (GABA) and other neurometabolites in the striatum and thalamus of 154 men. MATERIAL AND METHODS: GABA-edited and short echo-time MRS at 3T was used to assess brain levels of GABA, glutamate, total creatine (tCr) and other neurometabolites. Volumes of interest (VOIs) were placed into the striatum and thalamus of both hemispheres of 47 active welders, 20 former welders, 36 men with Parkinson's disease (PD), 12 men with hemochromatosis (HC), and 39 male controls. Linear mixed models were used to estimate the influence of Mn and Fe exposure on neurometabolites while simultaneously adjusting for cerebrospinal fluid (CSF) content, age and other factors. Exposure to Mn and Fe was assessed by study group, blood concentrations, relaxation rates R1 and R2* in the globus pallidus (GP), and airborne exposure (active welders only). RESULTS: The median shift exposure to respirable Mn and Fe in active welders was 23μg/m3 and 110μg/m3, respectively. Airborne exposure was not associated with any other neurometabolite concentration. Mn in blood and serum ferritin were highest in active and former welders. GABA concentrations were not associated with any measure of exposure to Mn or Fe. In comparison to controls, tCr in these VOIs was lower in welders and patients with PD or HC. Serum concentrations of ferritin and Fe were associated with N-acetylaspartate, but in opposed directions. Higher R1 values in the GP correlated with lower neurometabolite concentrations, in particular tCr (exp(β)=0.87, p<0.01) and choline (exp(β)=0.84, p=0.04). R2* was positively associated with glutamate-glutamine and negatively with myo-inositol. CONCLUSIONS: Our results do not provide evidence that striatal and thalamic GABA differ between Mn-exposed workers, PD or HC patients, and controls. This may be due to the low exposure levels of the Mn-exposed workers and the challenges to detect small changes in GABA. Whereas Mn in blood was not associated with any neurometabolite content in these VOIs, a higher metal accumulation in the GP assessed with R1 correlated with generally lower neurometabolite concentrations.
OBJECTIVE: Magnetic resonance spectroscopy (MRS) is a non-invasive method to quantify neurometabolite concentrations in the brain. Within the framework of the WELDOX II study, we investigated the association of exposure to manganese (Mn) and iron (Fe) with γ-aminobutyric acid (GABA) and other neurometabolites in the striatum and thalamus of 154 men. MATERIAL AND METHODS:GABA-edited and short echo-time MRS at 3T was used to assess brain levels of GABA, glutamate, total creatine (tCr) and other neurometabolites. Volumes of interest (VOIs) were placed into the striatum and thalamus of both hemispheres of 47 active welders, 20 former welders, 36 men with Parkinson's disease (PD), 12 men with hemochromatosis (HC), and 39 male controls. Linear mixed models were used to estimate the influence of Mn and Fe exposure on neurometabolites while simultaneously adjusting for cerebrospinal fluid (CSF) content, age and other factors. Exposure to Mn and Fe was assessed by study group, blood concentrations, relaxation rates R1 and R2* in the globus pallidus (GP), and airborne exposure (active welders only). RESULTS: The median shift exposure to respirable Mn and Fe in active welders was 23μg/m3 and 110μg/m3, respectively. Airborne exposure was not associated with any other neurometabolite concentration. Mn in blood and serum ferritin were highest in active and former welders. GABA concentrations were not associated with any measure of exposure to Mn or Fe. In comparison to controls, tCr in these VOIs was lower in welders and patients with PD or HC. Serum concentrations of ferritin and Fe were associated with N-acetylaspartate, but in opposed directions. Higher R1 values in the GP correlated with lower neurometabolite concentrations, in particular tCr (exp(β)=0.87, p<0.01) and choline (exp(β)=0.84, p=0.04). R2* was positively associated with glutamate-glutamine and negatively with myo-inositol. CONCLUSIONS: Our results do not provide evidence that striatal and thalamic GABA differ between Mn-exposed workers, PD or HC patients, and controls. This may be due to the low exposure levels of the Mn-exposed workers and the challenges to detect small changes in GABA. Whereas Mn in blood was not associated with any neurometabolite content in these VOIs, a higher metal accumulation in the GP assessed with R1 correlated with generally lower neurometabolite concentrations.
Authors: D Mergler; M Baldwin; S Bélanger; F Larribe; A Beuter; R Bowler; M Panisset; R Edwards; A de Geoffroy; M P Sassine; K Hudnell Journal: Neurotoxicology Date: 1999 Apr-Jun Impact factor: 4.294
Authors: Tomás R Guilarte; Jennifer L McGlothan; Mahaveer Degaonkar; Ming-Kai Chen; Peter B Barker; Tore Syversen; Jay S Schneider Journal: Toxicol Sci Date: 2006-09-12 Impact factor: 4.849
Authors: Eun-Young Lee; Michael R Flynn; Guangwei Du; Yunqing Li; Mechelle M Lewis; Amy H Herring; Eric Van Buren; Scott Van Buren; Lan Kong; Rebecca C Fry; Amanda M Snyder; James R Connor; Qing X Yang; Richard B Mailman; Xuemei Huang Journal: Toxicol Sci Date: 2016-01-14 Impact factor: 4.849
Authors: Jonathan E Myers; Jim teWaterNaude; Markus Fourie; H B Abie Zogoe; Inakshi Naik; Penny Theodorou; Halina Tassel; Aarti Daya; Mary Lou Thompson Journal: Neurotoxicology Date: 2003-08 Impact factor: 4.294
Authors: Alexey A Tinkov; Monica M B Paoliello; Aksana N Mazilina; Anatoly V Skalny; Airton C Martins; Olga N Voskresenskaya; Jan Aaseth; Abel Santamaria; Svetlana V Notova; Aristides Tsatsakis; Eunsook Lee; Aaron B Bowman; Michael Aschner Journal: Int J Mol Sci Date: 2021-04-28 Impact factor: 5.923
Authors: Anne Lotz; Beate Pesch; Swaantje Casjens; Martin Lehnert; Wolfgang Zschiesche; Dirk Taeger; Chien-Lin Yeh; Tobias Weiss; Tobias Schmidt-Wilcke; Clara Quetscher; Stefan Gabriel; Maria Angela Samis Zella; Dirk Woitalla; Ulrike Dydak; Christoph van Thriel; Thomas Brüning; Thomas Behrens Journal: Neurotoxicology Date: 2020-12-07 Impact factor: 4.398
Authors: Beate Pesch; Swaantje Casjens; Dirk Woitalla; Shalmali Dharmadhikari; David A Edmondson; Maria Angela Samis Zella; Martin Lehnert; Anne Lotz; Lennard Herrmann; Siegfried Muhlack; Peter Kraus; Chien-Lin Yeh; Benjamin Glaubitz; Tobias Schmidt-Wilcke; Ralf Gold; Christoph van Thriel; Thomas Brüning; Lars Tönges; Ulrike Dydak Journal: Cells Date: 2019-01-29 Impact factor: 6.600
Authors: Airton Cunha Martins; Patricia Morcillo; Omamuyovwi Meashack Ijomone; Vivek Venkataramani; Fiona Edith Harrison; Eunsook Lee; Aaron Blaine Bowman; Michael Aschner Journal: Int J Environ Res Public Health Date: 2019-09-22 Impact factor: 3.390